Astrazeneca (AZNCF) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for Astrazeneca (AZNCF) over the last 15 years, with Q3 2025 value amounting to $349.0 million.
- Astrazeneca's Other Non Operating Income rose 2737.23% to $349.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 209.95%. This contributed to the annual value of $1.3 billion for FY2021, which is 3443.28% up from last year.
- According to the latest figures from Q3 2025, Astrazeneca's Other Non Operating Income is $349.0 million, which was up 2737.23% from $371.0 million recorded in Q2 2025.
- In the past 5 years, Astrazeneca's Other Non Operating Income registered a high of $371.0 million during Q2 2025, and its lowest value of $265.0 million during Q1 2025.
- Its 5-year average for Other Non Operating Income is $316.2 million, with a median of $319.0 million in 2021.
- Examining YoY changes over the last 5 years, Astrazeneca's Other Non Operating Income showed a top increase of 2737.23% in 2025 and a maximum decrease of 1225.17% in 2025.
- Over the past 5 years, Astrazeneca's Other Non Operating Income (Quarter) stood at $335.0 million in 2021, then dropped by 12.54% to $293.0 million in 2022, then increased by 25.26% to $367.0 million in 2023, then fell by 25.34% to $274.0 million in 2024, then increased by 27.37% to $349.0 million in 2025.
- Its Other Non Operating Income stands at $349.0 million for Q3 2025, versus $371.0 million for Q2 2025 and $265.0 million for Q1 2025.